Clinical trial
A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to…
NCT00198523 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00198523 |
|---|---|
| Title | A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte |
| Official title | A Multi-Center, Randomized, Double Masked, Bioequivalence Study of Tobramycin and Prednisolone Acetate (0.3/1.0%, ISTA) Ophthalmic Suspension Compared to PredForte (1.0% Prednisolone Acetate, Allergan) Ophthalmic Suspension |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Eye Infections, Postoperative Complications |
| Intervention type | Drug |
| Interventions | Prednisolone and Tobramycin, Prednisolone |
| Enrollment | 132 |
| Start date | Jul 1, 2005 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Mar 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: